Document Detail


E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription.
MedLine Citation:
PMID:  9704927     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The E2F family of transcription factors are essential for the regulation of genes required for appropriate progression through the cell cycle. Five members of the E2F family have been previously reported, namely E2F1-5. All five are key elements in transcriptional regulation of essential genes, and they can be divided into two functional groups, those that induce S-phase progression when overexpressed in quiescent cells (E2Fs 1-3), and those that do not (E2Fs 4-5). Here, we describe the identification of a novel member of this family, which we refer to as E2F-6. E2F-6 shares significant homology with E2Fs 1-5, especially within the DNA binding, heterodimerization and marked box domains. Unlike E2Fs 1-5, E2F-6 lacks a transactivation and a pocket protein binding domain, hence, forms a unique third group within the E2F family. E2F-6 is a nuclear protein that can form heterodimers with the DP proteins (both DP-I and DP-2) in vitro and in vivo. Our results show that the complex formed between E2F-6 and the DP proteins, possesses high DNA binding activity, displaying a preference for a TTTCCCGC E2F recognition site, which is slightly different to the E2F consensus site derived from the E2 promoter (TTTCGCGC). In contrast to the other members of the E2F family, ectopic expression of E2F-6 inhibits transcription from promoters possessing E2F recognition sites rather than activating transcription. In addition, overexpression of E2F-6 suppresses the transactivational effects of coexpression of E2F-1 and DP-1. The inhibitory effect of E2F-6 is dependent on its DNA binding activity and its ability to form heterodimers with the DPs. Interestingly, ectopic expression of E2F-6 leads to accumulation of cells in S-phase. Our data suggest that E2F-6 expression delays the exit from S-phase rather than inducing S-phase, which further emphasizes the functional difference between E2F-6 and the previously known E2F family members.
Authors:
P Cartwright; H Müller; C Wagener; K Holm; K Helin
Related Documents :
12023277 - Transcriptional regulation of the pituitary vasopressin v1b receptor involves a gaga-bi...
17316977 - Probasin promoter assembles into a strongly positioned nucleosome that permits androgen...
9573187 - Transcriptional repression mediated by lysr-type regulator catr bound at multiple bindi...
8985357 - The epstein-barr virus ebna-1 promoter qp requires an initiator-like element.
20504647 - Density of sodium channels in insect synaptic nerve endings.
9435787 - Reactivity in vegetative incompatibility of the het-e protein of the fungus podospora a...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Oncogene     Volume:  17     ISSN:  0950-9232     ISO Abbreviation:  Oncogene     Publication Date:  1998 Aug 
Date Detail:
Created Date:  1998-09-02     Completed Date:  1998-09-02     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8711562     Medline TA:  Oncogene     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  611-23     Citation Subset:  IM    
Affiliation:
European Institute of Oncology, Department of Experimental Oncology, Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amino Acid Sequence
Animals
Base Sequence
Cell Cycle
Cell Cycle Proteins*
DNA, Complementary
DNA-Binding Proteins / genetics,  metabolism*
E2F6 Transcription Factor
Gene Expression
HL-60 Cells
Humans
Molecular Sequence Data
Nuclear Proteins / genetics,  metabolism*
Rabbits
Repressor Proteins / genetics,  metabolism*
Sequence Homology, Amino Acid
Tissue Distribution
Transcription Factor DP1
Transcription Factors / genetics,  metabolism*
Transcription, Genetic*
Tumor Cells, Cultured
Chemical
Reg. No./Substance:
0/Cell Cycle Proteins; 0/DNA, Complementary; 0/DNA-Binding Proteins; 0/E2F6 Transcription Factor; 0/E2F6 protein, human; 0/Nuclear Proteins; 0/Repressor Proteins; 0/TFDP1 protein, human; 0/TFDP2 protein, human; 0/Tfdp2 protein, mouse; 0/Transcription Factor DP1; 0/Transcription Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II.
Next Document:  An activated Rac mutant functions as a dominant negative for membrane ruffling.